Valproic Acid in Treating Patients With Kaposi's Sarcoma
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Valproic acid may help stop the growth of Kaposi's sarcoma cells by blocking the
enzymes necessary for tumor cell growth.
PURPOSE: This clinical trial is studying valproic acid in treating patients with HIV-related
Kaposi's sarcoma.
Phase:
N/A
Details
Lead Sponsor:
AIDS Malignancy Consortium
Collaborators:
National Cancer Institute (NCI) The Emmes Company, LLC The EMMES Corporation